Literature DB >> 23121279

Induction of cytochrome P450 enzymes: a view on human in vivo findings.

Janne Hukkanen1.   

Abstract

The induction of drug-metabolizing enzymes is a special case of pharmacokinetic interactions with consequences for the concurrent drug therapy. The most important enzymes affecting the pharmacokinetics of pharmaceuticals are cytochrome P450 (CYP) enzymes and their induction is often of utmost importance for the effects of the metabolized drugs. This review presents the current knowledge on the inducers of the specific CYP enzymes in humans. The focus is solely on human in vivo findings; in vitro results are referenced only when needed to interpret the induction mechanisms. As the mechanisms of CYP induction are important in understanding the effects of inducers, a concise overview of the various receptors affecting the induction of human CYP enzymes is presented.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23121279     DOI: 10.1586/ecp.12.39

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  16 in total

1.  Mediation by Placental DNA Methylation of the Association of Prenatal Maternal Smoking and Birth Weight.

Authors:  Andres Cardenas; Sharon M Lutz; Todd M Everson; Patrice Perron; Luigi Bouchard; Marie-France Hivert
Journal:  Am J Epidemiol       Date:  2019-11-01       Impact factor: 4.897

Review 2.  Cytochrome P450 interactions and clinical implication in rheumatology.

Authors:  Audrey Cayot; Davy Laroche; Anne Disson-Dautriche; Anaïs Arbault; Jean-Francis Maillefert; Paul Ornetti
Journal:  Clin Rheumatol       Date:  2014-06-14       Impact factor: 2.980

3.  Factors Contributing to Fentanyl Pharmacokinetic Variability Among Diagnostically Diverse Critically Ill Children.

Authors:  Fanuel T Hagos; Christopher M Horvat; Alicia K Au; Yvette P Conley; Lingjue Li; Samuel M Poloyac; Patrick M Kochanek; Robert S B Clark; Philip E Empey
Journal:  Clin Pharmacokinet       Date:  2019-12       Impact factor: 6.447

Review 4.  Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics.

Authors:  Ranjeet Prasad Dash; R Jayachandra Babu; Nuggehally R Srinivas
Journal:  Clin Pharmacokinet       Date:  2018-11       Impact factor: 6.447

5.  The effect of atorvastatin treatment on serum oxysterol concentrations and cytochrome P450 3A4 activity.

Authors:  Janne Hukkanen; Johanna Puurunen; Tuulia Hyötyläinen; Markku J Savolainen; Aimo Ruokonen; Laure Morin-Papunen; Matej Orešič; Terhi Piltonen; Juha S Tapanainen
Journal:  Br J Clin Pharmacol       Date:  2015-07-22       Impact factor: 4.335

Review 6.  Redox Signaling by Reactive Electrophiles and Oxidants.

Authors:  Saba Parvez; Marcus J C Long; Jesse R Poganik; Yimon Aye
Journal:  Chem Rev       Date:  2018-08-27       Impact factor: 60.622

Review 7.  Strategies for developing pregnane X receptor antagonists: Implications from metabolism to cancer.

Authors:  Sergio C Chai; William C Wright; Taosheng Chen
Journal:  Med Res Rev       Date:  2019-11-28       Impact factor: 12.944

8.  Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin.

Authors:  Genovefa Kolovou; Georgia Ragia; Vana Kolovou; Constantinos Mihas; Niki Katsiki; Ioannis Vasiliadis; Sophie Mavrogeni; Vassiliki Vartela; Anna Tavridou; Vangelis G Manolopoulos
Journal:  Open Cardiovasc Med J       Date:  2014-02-07

9.  Cytochrome P450 induction properties of food and herbal-derived compounds using a novel multiplex RT-qPCR in vitro assay, a drug-food interaction prediction tool.

Authors:  Xue Fen Koe; Tengku Sifzizul Tengku Muhammad; Alexander Shu-Chien Chong; Habibah Abdul Wahab; Mei Lan Tan
Journal:  Food Sci Nutr       Date:  2014-06-10       Impact factor: 2.863

10.  Effect of honokiol on the induction of drug-metabolizing enzymes in human hepatocytes.

Authors:  Yong-Yeon Cho; Hyeon-Uk Jeong; Jeong-Han Kim; Hye Suk Lee
Journal:  Drug Des Devel Ther       Date:  2014-11-03       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.